DexCom Inc (DXCM)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$66.95

Buy

$68.83

arrow-down$-1.98 (-2.87%)

Prices updated at 13 Dec 2025, 00:33 EST

Prices minimum 15 mins delay

Prices in USD

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	3,622m	4,033m
	2,289m	2,438m
	598m	600m
	16.50	14.88
	542m	576m
	917m	946m
Sales, General and administrative	1,185m	1,286m
Interest expenses	20m	19m
Provision for income taxes	169m	133m
Operating expenses	1,691m	1,838m
Income before taxes	710m	709m
Net income available to common shareholders	542m	576m
	1.4	1.46
Net interest income	115m	115m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.3	1.42
Free cash flow per share	1.1685	1.2882
Book value/share	5.8845	5.0653
Debt equity ratio	1.243788	0.647056

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	4,426m	4,301m
Current liabilities	1,556m	2,932m
Total capital	4,503m	3,340m
Total debt	2,594m	2,587m
Total equity	2,069m	2,103m
Total non current liabilities	-	-
Loans	2,434m	1,237m
Total assets	6,265m	6,485m
Total liabilities	-	-
Cash and cash equivalents	566m	606m
Common stock	385m	391m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	643m	568m
Cash dividends paid	-	-
	512m	631m
Investments (gains) losses	-507m	-207m
	568m	607m
Net income	-	-
	749m	990m
	-237m	-359m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.